Lower Intrinsic ADP-Stimulated Mitochondrial Respiration Underlies In Vivo Mitochondrial Dysfunction in Muscle of Male Type 2 Diabetic Patients
Open Access
- 1 November 2008
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 57 (11), 2943-2949
- https://doi.org/10.2337/db08-0391
Abstract
OBJECTIVE—A lower in vivo mitochondrial function has been reported in both type 2 diabetic patients and first-degree relatives of type 2 diabetic patients. The nature of this reduction is unknown. Here, we tested the hypothesis that a lower intrinsic mitochondrial respiratory capacity may underlie lower in vivo mitochondrial function observed in diabetic patients. RESEARCH DESIGN AND METHODS—Ten overweight diabetic patients, 12 first-degree relatives, and 16 control subjects, all men, matched for age and BMI, participated in this study. Insulin sensitivity was measured with a hyperinsulinemic-euglycemic clamp. Ex vivo intrinsic mitochondrial respiratory capacity was determined in permeabilized skinned muscle fibers using high-resolution respirometry and normalized for mitochondrial content. In vivo mitochondrial function was determined by measuring phosphocreatine recovery half-time after exercise using 31P-magnetic resonance spectroscopy. RESULTS—Insulin-stimulated glucose disposal was lower in diabetic patients compared with control subjects (11.2 ± 2.8 vs. 28.9 ± 3.7 μmol · kg−1 fat-free mass · min−1, respectively; P = 0.003), with intermediate values for first-degree relatives (22.1 ± 3.4 μmol · kg−1 fat-free mass · min−1). In vivo mitochondrial function was 25% lower in diabetic patients (P = 0.034) and 23% lower in first-degree relatives, but the latter did not reach statistical significance (P = 0.08). Interestingly, ADP-stimulated basal respiration was 35% lower in diabetic patients (P = 0.031), and fluoro-carbonyl cyanide phenylhydrazone–driven maximal mitochondrial respiratory capacity was 31% lower in diabetic patients (P = 0.05) compared with control subjects with intermediate values for first-degree relatives. CONCLUSIONS—A reduced basal ADP-stimulated and maximal mitochondrial respiratory capacity underlies the reduction in in vivo mitochondrial function, independent of mitochondrial content. A reduced capacity at both the level of the electron transport chain and phosphorylation system underlies this impaired mitochondrial capacity.Keywords
This publication has 30 references indexed in Scilit:
- Muscle Mitochondrial ATP Synthesis and Glucose Transport/Phosphorylation in Type 2 DiabetesPLoS Medicine, 2007
- Family History of Diabetes Links Impaired Substrate Switching and Reduced Mitochondrial Content in Skeletal MuscleDiabetes, 2007
- Patients with type 2 diabetes have normal mitochondrial function in skeletal muscleDiabetologia, 2007
- Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 DiabetesThe New England Journal of Medicine, 2004
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003
- Cellular mechanisms of insulin resistanceJCI Insight, 2000
- Comparisons of ATP turnover in human muscle during ischemic and aerobic exercise using 31P magnetic resonance spectroscopyMagnetic Resonance in Medicine, 1994
- Mitochondrial respiratory parameters in cardiac tissue: A novel method of assessment by using saponin-skinned fibersBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1987
- Resynthesis of creatine phosphate in human muscle after exercise in relation to intramuscular pH and availability of oxygenScandinavian Journal of Clinical and Laboratory Investigation, 1979
- Diet, Muscle Glycogen and Physical PerformanceActa Physiologica Scandinavica, 1967